Regen BioPharma Inc (RGBP) - Financial and Strategic SWOT Analysis Review

  • ID: 4278574
  • SWOT Analysis
  • 25 pages
  • GlobalData
1 of 4
Summary

Regen BioPharma Inc (Regen BioPharma), a subsidiary of Bio-Matrix Scientific Group Inc is a biotechnology company that concentrates on the development of immunotherapies and cancer stem cell therapies. The company’s product pipeline includes HemaXellerate, dCellVax, DiffronC, small molecule targeting cancer stem cell genes, telomeres and genomic integrity. It provides products for aplastic anemia, myelodysplastic syndrome, solid tumors and acute leukemia, breast cancer, hematopoiesis and liver cancer, among others. The company spans its expertise in the development of therapies including small molecules, stem cell treatments and the body's own immune system. Regen BioPharma is headquartered in La Mesa, California, the US.

Regen BioPharma Inc Key Recent Developments

Oct 30, 2017: Regen BioPharma Announces Former Eli Lilly Executive and Current CVS Board Member will Lead Newly Formed Business Advisory Board (BAB)
Oct 23, 2017: Regen BioPharma Begins Program to Determine the 3-Dimensional Crystal Structure of NR2F6
Jul 12, 2017: Regen BioPharma Researchers Discover New Dynamic Compound Which Modulates the NR2F6 Checkpoint
May 16, 2017: Regen BioPharma Sees Additional Positive Results on its Medicinal Chemistry Optimization for Modulating NR2F6 Checkpoint for Treating Cancer and Autoimmune Diseases
Apr 18, 2017: Regen BioPharma Identifies Three New Series of Compounds That Activate NR2F6

This comprehensive SWOT profile of Regen BioPharma Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Regen BioPharma Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
Section 1 - About the Company
  • Regen BioPharma Inc - Key Information
  • Regen BioPharma Inc - Overview
  • Regen BioPharma Inc - Key Employees
  • Regen BioPharma Inc - Key Employee Biographies
  • Regen BioPharma Inc - Key Operational Heads
  • Regen BioPharma Inc - Major Products and Services
  • Regen BioPharma Inc - History
  • Regen BioPharma Inc - Company Statement
  • Regen BioPharma Inc - Locations And Subsidiaries
  • Regen BioPharma Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Regen BioPharma Inc - Business Description
  • Regen BioPharma Inc - Corporate Strategy
  • Regen BioPharma Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Regen BioPharma Inc - Strengths
  • Regen BioPharma Inc - Weaknesses
  • Regen BioPharma Inc - Opportunities
  • Regen BioPharma Inc - Threats
  • Regen BioPharma Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Regen BioPharma Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Regen BioPharma Inc, Key Information
  • Regen BioPharma Inc, Key Ratios
  • Regen BioPharma Inc, Share Data
  • Regen BioPharma Inc, Major Products and Services
  • Regen BioPharma Inc, History
  • Regen BioPharma Inc, Key Employees
  • Regen BioPharma Inc, Key Employee Biographies
  • Regen BioPharma Inc, Key Operational Heads
  • Regen BioPharma Inc, Other Locations
  • Regen BioPharma Inc, Subsidiaries
  • Regen BioPharma Inc, Key Manufacturing facilities
  • Regen BioPharma Inc, Key Competitors
  • Regen BioPharma Inc, SWOT Analysis
  • Regen BioPharma Inc, Ratios based on current share price
  • Regen BioPharma Inc, Annual Ratios
  • Regen BioPharma Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Regen BioPharma Inc, Performance Chart
  • Regen BioPharma Inc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll